Let some people get future-ready first – under this motto more than 800 delegates met at the 2022 China International Vaccine Innovation Summit (HVIS) in Renaissance Beijing Capital Hotel from 8th August to 9th August. Top scientists from CDC and biopharm industry presented and discussed the mRNA therapy, new vaccines from the perspective of policies and regulations, marketing analysis, R&D innovation and the process development in the field of vaccines and nucleic acid drugs.
We, the ALIT Biotech Co., Ltd. was invited to this summit and displayed the innovative instruments at our booth NO. E8. We generated a lot of interest for our cGMP compliant image-based cell analyzer series, the Countstar Rigel and Countstar Altair systems. A strong focus in the talks was placed on the capability of our analyzers, needing only a small volume of sample, and combining bright field and fluorescent microscopy in a single measurement sequence to obtain a bundle of indispensable process data. A further aspect was the general potential of our devices to get integrated in fully automated process environments. That will help the customers in vaccines to simplify your workflow, allowing for increased productivity and efficiency.
The on-site customers from the vaccine industry are glad to see that Countstar cell analyzers can help them to evaluate the process based on the cell. Such as the cell transfection and the total cell concentration and the viability that will define the status of the cell culture.
Countstar cell analyzers are the image-based cytometry, can help monitor from R&D to production processes and ensure reproducibility and consistency. ALIT Biotech thanks all visitors for stepping by at our booth and hope to get further cooperation with the customers from the biopharm industry to make the life healthier.
